AM Technical Solutions Acquires Sequence Inc. to Scale Project Delivery and Workforce Innovation for the Life Sciences Industry

AM Technical Solutions (AMTS) has acquired Sequence Inc. in a strategic move aimed at enhancing project delivery and workforce innovation within the life sciences sector. The deal, announced on July 8, 2026, involves an undisclosed transaction value and signifies AMTS's commitment to addressing the pressing challenges faced by the industry, particularly the talent shortage and the need for expedited project execution.

The acquisition combines AMTS's extensive global project delivery expertise with Sequence's specialized capabilities in engineering, commissioning, qualification, and workforce training. This integration is expected to bolster both companies' ability to deliver complex projects efficiently while maintaining high standards of quality and compliance. The partnership aims to streamline operations and improve outcomes for clients by leveraging the strengths of both organizations.

A key component of this acquisition is Sequence's mock pharmaceutical training facility, which is designed to replicate real-world manufacturing environments. This facility will enable personnel to receive hands-on training before they enter client sites, thereby reducing ramp-up times and enhancing performance from the outset of projects. By preparing a workforce that is project-ready, AMTS and Sequence are positioning themselves to better meet the demands of a rapidly evolving life sciences landscape.

The life sciences sector is currently experiencing significant growth, driven by increased global demand for advanced manufacturing capabilities. This acquisition reflects a broader trend in the industry, where companies are increasingly seeking integrated solutions that can address the complexities of project delivery. With the combined expertise of AMTS and Sequence, clients can expect a more cohesive approach to project management, from initial planning through to operational readiness.

As the life sciences industry continues to evolve, the implications of this acquisition extend beyond the immediate benefits to AMTS and Sequence. The merger represents a strategic response to the industry's ongoing challenges, particularly the need for a skilled workforce capable of navigating the complexities of modern manufacturing processes. By fostering innovation and enhancing training capabilities, AMTS and Sequence are not only addressing current market demands but also setting a foundation for future growth and success in the sector.